search for




 

Parenteral Nutrition Support in Preterm Infants
미숙아에서의 정맥 영양지원
JOURNAL OF CLINICAL NUTRITION 2014;6:51-55
Published online August 30, 2014
© 2014 The Korean Society for Parenteral and Enteral Nutrition.

Ji Hye Yoon
윤지혜

Department of Pharmacy, Samsung Medical Center, Seoul, Korea
삼성서울병원 약제부
Received July 28, 2014; Revised August 8, 2014; Accepted August 11, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Nutrition support for preterm infants is important to achievement of a postnatal growth rate optimizing normal fetal intrauterine growth rates and for improvement of patient outcome. However, sufficient nutrient delivery is not easy because of underlying illness. Although enteral nutrition (EN) is preferred over parenteral nutrition (PN), immature gastrointestinal features and inability to suck and swallow until 33 weeks’ gestation disrupt. In patients with inability to tolerate adequate EN for more than 2 or 3 days, to optimize nutrition support and minimize complications, PN should begin within 24 hours after birth. The purpose of this study is to review the PN in preterm infants for the most appropriate nutritional support to meet each patient’s requirement.
Keywords : Nutrition support, Parenteral nutrition, Premature
References
  1. Chang YS, Park WS. Strategies to overcome the limit of viability of microprimie. Neonatal Med 2013;20(3):258-67.
    CrossRef
  2. American Academy of Pediatrics Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics 1985;75(5):976-86.
    Pubmed
  3. Chang YS. Nutritional support in premature infants. Hanyang Med Rev 2011;31(4):246-53.
    CrossRef
  4. Lapillonne A, Griffin IJ. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr 2013;162(3 Suppl):S7-16.
    Pubmed CrossRef
  5. Stephens BE, Walden RV, Gargus RA, Tucker R, McKinley L, Mance M, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009;123(5):1337-43.
    Pubmed CrossRef
  6. Denne SC, Karn CA, Wang J, Liechty EA. Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns. Am J Physiol 1995;269(2 Pt 1):E361-7.
    Pubmed
  7. Thureen PJ, Hay WW. Neonatal nutrition and metabolism. 2nd ed. Cambridge:Cambridge University Press;2006.
    KoreaMed CrossRef
  8. Ziegler EE, O'Donnell AM, Nelson SE, Fomon SJ. Body composition of the reference fetus. Growth 1976;40(4):329-41.
    Pubmed
  9. Denne SC, Poindexter BB. Evidence supporting early nutritional support with parenteral amino acid infusion. Semin Perinatol 2007;31(2):56-60.
    Pubmed CrossRef
  10. Van Goudoever JB, Colen T, Wattimena JL, Huijmans JG, Carnielli VP, Sauer PJ. Immediate commencement of amino acid supplementation in preterm infants: effect on serum amino acid concentrations and protein kinetics on the first day of life. J Pediatr 1995;127(3):458-65.
    CrossRef
  11. Rivera A Jr, Bell EF, Bier DM. Effect of intravenous amino acids on protein metabolism of preterm infants during the first three days of life. Pediatr Res 1993;33(2):106-11.
    Pubmed CrossRef
  12. Thureen PJ, Melara D, Fennessey PV, Hay WW Jr. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res 2003;53(1):24-32.
    Pubmed CrossRef
  13. Van den Akker CH, Van Goudoever JB. Recent advances in our understanding of protein and amino acid metabolism in the human fetus. Curr Opin Clin Nutr Metab Care 2010;13(1):75-80.
    Pubmed CrossRef
  14. te Braake FW, van den Akker CH, Wattimena DJ, Huijmans JG, van Goudoever JB. Amino acid administration to premature infants directly after birth. J Pediatr 2005;147(4):457-61.
    Pubmed CrossRef
  15. Hans DM, Pylipow M, Long JD, Thureen PJ, Georgieff MK. Nutritional practices in the neonatal intensive care unit: analysis of a 2006 neonatal nutrition survey. Pediatrics 2009;123(1):51-7.
    Pubmed CrossRef
  16. Bonsante F, Iacobelli S, Latorre G, Rigo J, De Felice C, Robillard PY, et al. Initial amino acid intake influences phosphorus and calcium homeostasis in preterm infants--it is time to change the composition of the early parenteral nutrition. PLoS One 2013;8(8):e72880.
    Pubmed KoreaMed CrossRef
  17. Ichikawa G, Watabe Y, Suzumura H, Sairenchi T, Muto T, Arisaka O. Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth. J Pediatr Endocrinol Metab 2012;25(3-4):317-21.
    Pubmed CrossRef
  18. Moltu SJ, Strømmen K, Blakstad EW, Almaas AN, Westerberg AC, Brække K, et al. Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia--a randomized, controlled trial. Clin Nutr 2013;32(2):207-12.
    Pubmed CrossRef
  19. Mizumoto H, Mikami M, Oda H, Hata D. Refeeding syndrome in a small-for-dates micro-preemie receiving early parenteral nutrition. Pediatr Int 2012;54:715-7.
    Pubmed CrossRef
  20. Merritt R, DeLegge MH, Holcombe B, Mueller C, Ochoa J, Smith KR, et al. The A.S.P.E.N. nutrition support practice manual guide. 2nd ed. Silver Spring:American Society for Parenteral and Enteral Nutrition;2005.
  21. Ridout E, Melara D, Rottinghaus S, Thureen PJ. Blood urea nitrogen concentration as a marker of amino-acid intolerance in neonates with birthweight less than 1250 g. J Perinatol 2005;25(2):130-3.
    Pubmed CrossRef
  22. G?bel Y, Koletzko B, B?hles HJ, Engelsberger I, Forget D, Le Brun A, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 2003;37(2):161-7.
    Pubmed CrossRef
  23. Rubin M, Harell D, Naor N, Moser A, Wielunsky E, Merlob P, et al. Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. JPEN J Parenter Enteral Nutr 1991;15(6):642-6.
    Pubmed CrossRef
  24. Socha P, Koletzko B, Demmelmair H, Jankowska I, Stajniak A, Bednarska-Makaruk M, et al. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols. Nutrition 2007;23(2):121-6.
    Pubmed CrossRef
  25. Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121(3):e678-86.
    Pubmed CrossRef
  26. Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil:a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr 2012;36(1 Suppl):81S-94S.
    Pubmed KoreaMed CrossRef
  27. Kim MJ, Bae HJ, Cho YS, Kim KS, Kim HS, Lee HS, et al. Effects of SMOFlipid on prophylaxis of cholestasis in premature very low birth weight infants. JKSPEN 2013;5(2):67-75.
  28. Kerner JA Jr, Poole RL. The use of IV fat in neonates. Nutr Clin Pract 2006;21(4):374-80.
    CrossRef
  29. Valentine CJ, Puthoff TD. Enhancing parenteral nutrition therapy for the neonate. Nutr Clin Pract 2007;22(2):183-93.
    CrossRef
  30. Denne SC, Kalhan SC. Glucose carbon recycling and oxidation in human newborns. Am J Physiol 1986;251(1 Pt 1):E71-7.
    Pubmed
  31. Hertz DE, Karn CA, Liu YM, Liechty EA, Denne SC. Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns. J Clin Invest 1993;92(4):1752-8.
    Pubmed KoreaMed CrossRef
  32. Sunehag AL, Haymond MW. Glucose extremes in newborn infants. Clin Perinatol 2002;29(2):245-60.
    CrossRef
  33. Mitanchez D. Glucose regulation in preterm newborn infants. Horm Res 2007;68(6):265-71.
    Pubmed CrossRef
  34. Hay WW Jr. Strategies for feeding the preterm infant. Neonatology 2008;94(4):245-54.
    Pubmed KoreaMed CrossRef
  35. Langdon DR, Stanley CA, Sperling MA. Hypoglycemia in the infant and child. In: Sperling M, ed. Pediatric endocrinology. 3rd ed. Philadelphia:Saunders Elsevier;2008:422-3.
    CrossRef
  36. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118(5):1811-8.
    Pubmed CrossRef
  37. Cowett RM, Farrag HM. Selected principles of perinatalneonatal glucose metabolism. Semin Neonatol 2004;9(1):37-47.
    CrossRef
  38. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Ahluwalia JS, Vanhole C, Palmer C, et al. A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE"(neonatal insulin replacement therapy in Europe). BMC Pediatr 2007;7:29.
    Pubmed KoreaMed CrossRef
  39. Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005;10(4):377-87.
    Pubmed CrossRef
  40. Kairamkonda VR, Khashu M. Controversies in the management of hyperglycemia in the ELBW infant. Indian Pediatr 2008;45(1):29-38.
    Pubmed
  41. Yoo HS, Ahn SY, Lee MS, Han YM, Sung SI, Chang YS, et al. Permissive hyperglycemia in extremely low birth weight infants. J Korean Med Sci 2013;28(3):450-60.
    Pubmed KoreaMed CrossRef
  42. Ditzenberger GR, Collins SD, Binder N. Continuous insulin intravenous infusion therapy for VLBW infants. J Perinat Neonatal Nurs 1999;13(3):70-82.
    Pubmed CrossRef
  43. Poindexter BB, Karn CA, Denne SC. Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants. J Pediatr 1998;132(6):948-53.
    CrossRef

June 2021, 13 (1)